COVID-19
COVID-19: Another Study Suggests Pfizer/BioNTech Vaccine is Capable of Neutralizing UK Variant
2021-01-20
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17